Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NTRB

Nutriband Inc

Oct 30 • 04:00PM ET

6.91

-0.02 -0.29 %

Healthcare • Biotechnology • USA • NASD

Peers: JNJ PFE MRK ABT BMY LLY GILD AMGN BIIB VRTX

| Held by: VTI VXF IWC IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.87	Insider Own	53.82%	Shs Outstand	12.02M	Perf Week	-1.29%
Market Cap	83.16M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	5.56M	Perf Month	-4.95%
Enterprise Value	76.43M	PEG	-	EPS next Q	-2.13	Inst Own	2.89%	Short Float	2.08%	Perf Quarter	-6.50%
Income	-32.08M	P/S	32.23	EPS this Y	-526.26%	Inst Trans	2.31%	Short Ratio	1.35	Perf Half Y	9.68%
Sales	2.58M	P/B	9.78	EPS next Y	-	ROA	-86.25%	Short Interest	0.12M	Perf YTD	46.71%
Book/sh	0.71	P/C	11.88	EPS next 5Y	-	ROE	-98.00%	52W High	11.78 -41.34%	Perf Year	9.68%
Cash/sh	0.58	P/FCF	-	EPS past 3/5Y	-7.15% -18.10%	ROIC	-372.84%	52W Low	3.72 85.64%	Perf 3Y	65.31%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	14.58% 41.99%	Gross Margin	32.56%	Volatility	7.91% 7.16%	Perf 5Y	-68.99%
Dividend TTM	-	EV/Sales	29.62	EPS Y/Y TTM	-251.69%	Oper. Margin	-264.04%	ATR (14)	0.53	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.70	Sales Y/Y TTM	42.92%	Profit Margin	-1244.44%	RSI (14)	44.83	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	4.78	EPS Q/Q	-1276.65%	SMA20	-7.28%	Beta	1.54	Target Price	15.00
Payout	-	Debt/Eq	0.03	Sales Q/Q	40.56%	SMA50	-1.75%	Rel Volume	0.34	Prev Close	6.93
Employees	-	LT Debt/Eq	0.01	Earnings	Oct 01	SMA200	0.37%	Avg Volume	85.99K	Price	6.91
IPO	Nov 30, 2017	Option/Short	No / Yes	EPS/Sales Surpr.	0.00% 0.00%	Trades		Volume	29,109	Change	-0.29%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-22-25	Initiated	Noble Capital Markets	Outperform	$13

Oct-28-25 11:05AM	REPEAT - Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch (GlobeNewswire) +10.38%
07:00AM	Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch (GlobeNewswire)
Oct-27-25 07:00AM	Nutriband Co-Founder Gareth Sheridan Returns as CEO (GlobeNewswire)
Oct-10-25 07:00AM	Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch (GlobeNewswire) -5.06%
Oct-08-25 08:30AM	Nutriband Files Provisional Patent Application for Enhanced Transdermal Abuse Deterrent Technology (GlobeNewswire) +8.42%
06:30AM	Loading…
06:30AM	Nutriband To Present at the Noble Capital Markets' Emerging Growth Virtual Equity Conference (GlobeNewswire)
Sep-25-25 08:00AM	11 Company Presentations Today at The MicroCap Rodeo Conference (ACCESSWIRE)
Sep-24-25 04:05PM	Nutriband Inc. to Present at the MicroCap Rodeo Conference (GlobeNewswire)
Sep-10-25 09:15AM	Nutriband Inc. Quarterly Report Highlights Record Revenue for Q2, 2025 up 50.87% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl (GlobeNewswire)
Sep-09-25 06:45PM	Nutriband Inc. (NTRB) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
Sep-03-25 04:01PM	Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $5,306,000 (GlobeNewswire)
Aug-27-25 06:20PM	Phibro Animal Health (PAHC) Tops Q4 Earnings and Revenue Estimates (Zacks)
Aug-18-25 09:00AM	Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025 (GlobeNewswire)
Aug-14-25 08:10AM	MediWound (MDWD) Reports Q2 Loss, Beats Revenue Estimates (Zacks) -5.41%
Aug-13-25 08:15AM	ARS Pharmaceuticals, Inc. (SPRY) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
06:55PM	Loading…
Aug-11-25 06:55PM	Assertio (ASRT) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
05:00AM	Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election (GlobeNewswire)
Aug-08-25 08:00AM	FDA Grants Nutriband Meeting Request for Aversa Fentanyl Abuse Deterrent Fentanyl Patch (GlobeNewswire)
Aug-07-25 08:05AM	Aclaris Therapeutics (ACRS) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
Jul-18-25 09:15AM	Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval (GlobeNewswire)
Jul-02-25 08:05AM	Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval (GlobeNewswire) +33.67%
Jul-01-25 07:00AM	Nutriband Inc. added to the Russell Microcap Index, Russell Microcap Growth Index, Russell 3000E Index and Russell 3000E Growth Index (GlobeNewswire)
Jun-18-25 07:00AM	Nutriband and Kindeva Complete Commercial Manufacturing Process Scale-up for Aversa Fentanyl Abuse Deterrent Fentanyl Patch (GlobeNewswire)
Jun-09-25 07:30AM	Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology (GlobeNewswire)
Jun-03-25 08:00AM	Nutriband Inc. to present at the 2025 Noble Capital Markets Virtual Equity Conference (GlobeNewswire)
Jun-02-25 08:00AM	Nutriband Inc. Quarterly Report Highlights Record Revenue for Q1, 2025 up 63% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl (GlobeNewswire) +24.77%
May-30-25 05:20PM	Nutriband Inc. (NTRB) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
May-27-25 08:00AM	IBN Announces Latest Episode of The BioMedWire Podcast Featuring Gareth Sheridan, CEO of Nutriband Inc. (GlobeNewswire) +9.12%
Apr-30-25 07:30AM	Nutriband CEO Publishes Letter to Shareholders (GlobeNewswire) +21.13%
Apr-11-25 07:00AM	Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology (GlobeNewswire)
05:41PM	Loading…
Apr-04-25 05:41PM	UPDATE Nutriband Signs Associate Partnership with Charlotte FC (GlobeNewswire) -5.74%
07:00AM	Nutriband Signs Partnership Agreement with Charlotte FC (GlobeNewswire)
Feb-21-25 07:00AM	Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development. (GlobeNewswire)
Feb-13-25 07:00AM	Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa Fentanyl Abuse Deterrent Fentanyl Patch (GlobeNewswire) +6.32%
Feb-11-25 09:00AM	Nutriband Inc. Announces Olympian Anastasia Nichita to Advisory Board (GlobeNewswire)
Feb-07-25 08:45AM	Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa (GlobeNewswire) +17.09%
Dec-31-24 07:00AM	Nutriband Issues Letter to Shareholders (GlobeNewswire) +12.68%
Dec-28-24 09:30AM	Nutriband extends Chinese patent to Macao for AVERSA technology (TipRanks)
Dec-27-24 09:25AM	Nutriband Extends Chinese Patent to Macao for its AVERSA Abuse Deterrent Transdermal Technology (GlobeNewswire)
Dec-04-24 09:00AM	Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025 (GlobeNewswire) +5.07%
07:00AM	Nutriband Inc. to Present at The 2024 Noble Conference in Boca Raton on December 4th (GlobeNewswire)
Nov-27-24 07:00AM	Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa Abuse Deterrent Transdermal Technology (GlobeNewswire)
Oct-31-24 08:35AM	Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application (ACCESSWIRE)
Oct-17-24 07:00AM	Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica (ACCESSWIRE) -5.59%
Oct-02-24 07:00AM	Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17 (ACCESSWIRE)
Sep-24-24 08:45AM	As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse (GlobeNewswire)
07:00AM	Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology (ACCESSWIRE)
Sep-20-24 06:50AM	Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch (ACCESSWIRE) +10.18%
Sep-16-24 04:00PM	Nutriband Inc. Authorizes $1M Share Buyback Program (ACCESSWIRE) +24.34%
Sep-04-24 07:00AM	Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025 (ACCESSWIRE) -9.55%
Jul-19-24 07:00AM	Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25 (ACCESSWIRE) +12.77%
Jul-15-24 07:00AM	Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology (ACCESSWIRE)
Jun-25-24 06:52AM	NTRB Stock Earnings: Nutriband Reported Results for Q1 2024 (InvestorPlace)
Jun-20-24 07:00AM	Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl (ACCESSWIRE) +11.18%
Jun-03-24 07:00AM	Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year (ACCESSWIRE) +13.03%
May-21-24 07:00AM	Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on May 30 (ACCESSWIRE)
May-16-24 07:00AM	Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors (ACCESSWIRE) -6.53%
May-10-24 09:00AM	Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV (ACCESSWIRE)
May-03-24 11:54AM	NTRB Stock Earnings: Nutriband Reported Results for Q4 2023 (InvestorPlace)
Apr-25-24 07:00AM	IBN Coverage Initiated for Nutriband Inc. (GlobeNewswire) -5.19%
Apr-24-24 07:00AM	Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA Submission (ACCESSWIRE) +8.15%
Apr-23-24 07:00AM	Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group (ACCESSWIRE)
Apr-19-24 07:00AM	Nutriband Inc. Announces $8.4M Private Placement (ACCESSWIRE)
Apr-01-24 07:00AM	Nutriband Inc. Begins Manufacturing for Major Sports Brand Licensee Fit for Life Group, Whose Collection of Partnered Brands Include Reebok, Adidas and New Balance (ACCESSWIRE) +7.96%
Mar-27-24 05:50AM	Nutriband Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA(R) Fentanyl Transdermal Patch (ACCESSWIRE) +33.22%
Mar-25-24 07:00AM	Nutriband Announces Data Supporting Need for Safer Abuse-Deterrent Transdermal Patches Presented at 2024 American Academy of Pain Medicine Annual Meeting (ACCESSWIRE)
Mar-04-24 07:00AM	Prescription Transdermal Patch Abuse and Accidental Pediatric Exposure Remains a Serious Problem in the United States - Surveillance Data to Be Presented at 2024 American Academy of Pain Medicine Annual Meeting (ACCESSWIRE)
Jan-29-24 07:00AM	Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st (ACCESSWIRE)
Jan-26-24 07:00AM	Nutriband CEO Publishes Letter to Shareholders (ACCESSWIRE)
Jan-05-24 09:15AM	Nutriband Signs Commercial Development and Clinical Supply Agreement With Kindeva Drug Delivery for Aversa(TM) Fentanyl, an Abuse Deterrent Fentanyl Patch (ACCESSWIRE) +16.12%
Dec-18-23 11:52AM	NTRB Stock Earnings: Nutriband Reported Results for Q3 2023 (InvestorPlace)
Nov-28-23 07:00AM	Nutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and Cooling (ACCESSWIRE) -7.72%
Nov-08-23 07:00AM	Nutriband Inc. Signs Supplier Agreement With KT Tape, the World Leader in Kinesiology Tape (ACCESSWIRE)
Oct-11-23 07:42AM	Nutribands Aversa(TM) Buprenoprhine May Reach Peak Annual Sales of $70-130 Million Based on Market Assessment by Leading Healthcare Consulting Firm (ACCESSWIRE)
Sep-20-23 09:15AM	Nutriband Unveils Groundbreaking Innovation in Transdermal Medications (News Direct)
07:30AM	Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent Technology (ACCESSWIRE)
Sep-12-23 07:00AM	Nutriband Inc. Receives Five Nominations in the Pharma Industry Awards 2023 (ACCESSWIRE) -10.18%
Sep-11-23 07:00AM	Nutriband Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update (ACCESSWIRE) +8.78%
Aug-30-23 08:00AM	Nutriband Inc. Announces Donovan McNabb as AI Tape Brand Ambassador (ACCESSWIRE)
Jul-27-23 08:30AM	Nutriband Inc. Launches AI Tape Brand Direct-to Consumer Offerings (News Direct) +14.60%
Jul-14-23 09:20AM	Nutriband Increases Existing Credit Line to $5 Million USD for the Development of its AVERSA(TM) Platform Towards FDA Submission (ACCESSWIRE) +34.58%
Jun-23-23 07:00AM	Nutriband Receives Notice of Allowance for U.S. Patent Covering Transdermal Abuse Deterrent Technology (ACCESSWIRE) -7.88%
May-10-23 08:00AM	Nutriband to Attend 2023 BIO International Convention (ACCESSWIRE) -12.40%
Apr-29-23 08:13AM	Nutriband Full Year 2023 Earnings: Misses Expectations (Simply Wall St.)
Apr-27-23 08:00AM	Nutriband Inc. Reports Revenue Up 46% in Fiscal 2023 (ACCESSWIRE)
Apr-24-23 09:00AM	Keynotes, Educational Panels and 77 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 25-27, 2023 at the Horseshoe Hotel & Casino in Las Vegas, NV (ACCESSWIRE)
Apr-19-23 07:00AM	Nutriband Inc. to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023 (ACCESSWIRE) +5.76%
Apr-04-23 07:00AM	Nutriband With Kindeva Drug Delivery Select Aversa(TM) Fentanyl Abuse Deterrent Formulation for Commercial Scale Manufacturing Process Development (ACCESSWIRE)
Mar-28-23 08:00AM	Nutriband Secures $2 Million Line of Credit Financing Facility to be Used for Commercialization of AVERSA(TM) Abuse-Deterrent Transdermal Technology (ACCESSWIRE)
Mar-08-23 08:00AM	Nutriband Inc Joins Webull Corporate Communications Service Platform (ACCESSWIRE)
Mar-02-23 08:00AM	Nutriband COO Alan Smith Ph.D. Selected for FDA Center for Research on Complex Generics Stakeholder Expert Committee (ACCESSWIRE)
Feb-15-23 06:00AM	Nutriband Inc. to File for Product Distribution Permit in South America with Ecuador's Health Register (ACCESSWIRE)
Jan-24-23 06:00AM	Nutriband Inc. to Present at the 2023 Transdermal and Microneedle Conference (ACCESSWIRE)
Jan-05-23 06:00AM	Nutriband Inc. Commences Trading on Upstream Under NTRB (ACCESSWIRE)
Dec-30-22 06:30AM	Nutriband Inc. Will Be the First Company to Dual List on Upstream (ACCESSWIRE)
Dec-29-22 06:30AM	Nutriband Inc. to Officially Launch AI Tape brand in Q1 2023 (ACCESSWIRE)
Dec-14-22 07:00AM	Nutriband Approved for Dual Listing on Upstream (ACCESSWIRE)
06:00AM	Nutriband Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R) (ACCESSWIRE)
Dec-05-22 07:00AM	Nutriband Inc. Reports Record Revenue Up 118% YoY in Q3 (ACCESSWIRE)
Dec-03-22 07:50AM	Nutriband Inc.'s (NASDAQ:NTRB) CEO Compensation Looks Acceptable To Us And Here's Why (Simply Wall St.)

Nutriband, Inc. engages in the development of a portfolio of transdermal pharmaceutical products. It operates through the Pocono Pharmaceuticals and 4P Therapeutics segments. The Pocono Pharmaceuticals segment relates to a coated products manufacturing entity. The 4P Therapeutics segment performs contract research and development services. The company was founded by Gareth R. Sheridan and Serguei Melnik in 2012 and is headquartered in Orlando, FL.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NTRB

Nutriband Inc

Upgrade your FINVIZ experience